Highest-materiality recent filing
AMN Healthcare Q1 2026 revenue $1.38B, adjusted EBITDA $166M, adjusted EPS $2.10 (up 366% YoY)
GAAP diluted EPS $1.59; adjusted diluted EPS $2.10, up 366% vs Q1 2025.
AMN Healthcare Q4 2025 revenue $748M, GAAP loss ($0.20)/share; FY revenue down 8%
Q4 revenue $748.2M (+2% YoY); net loss ($7.7M); diluted EPS ($0.20).
AMN Healthcare Q3 revenue down 8% to $635M; adjusted EPS falls 36%
GAAP net income $29.3M ($0.76 diluted EPS) vs $7.0M ($0.18) a year ago; adjusted EPS $0.39, down 36%.
AMN Healthcare issues $400M 6.5% notes due 2031, amends credit facility to redeem $500M 2027 notes
Issued $400M aggregate principal of 6.500% Senior Notes due Jan 15, 2031; interest payable semi-annually.
AMN Healthcare prices $400M 6.5% senior notes due 2031; to redeem $500M 4.625% notes due 2027
Issued $400M senior unsecured notes due 2031 at 6.500% interest, priced at 100% of face value.
AMN Healthcare Q2 revenue down 11% to $658M; GAAP loss of $3.02/share, adj EPS $0.30
Revenue $658.2M (-11% YoY); net loss $116.2M vs not meaningful in Q2 2024.
AMN Healthcare Q1 revenue $690M, GAAP loss $0.03/sh; adjusted EPS $0.45
Revenue $689.5M, down 16% YoY; gross profit $198.1M, down 23% YoY.
AMN Healthcare Q4 revenue $735M, GAAP loss of $4.90/share, adj EPS $0.75, FY revenue down 21%
Q4 2024 revenue $734.7M, down 10% YoY; full-year revenue $2,983.8M, down 21% YoY.
AMN Healthcare Q3 2024 revenue down 19%; GAAP EPS $0.18, adjusted EPS $0.61
Revenue $687.5M, down 19% YoY; net income $7.0M (-87%); GAAP EPS $0.18.
AMN Healthcare appoints Brian Scott as CFO/COO, effective Nov 21, 2024
Brian Scott returns to AMN as CFO/COO after serving as CFO/CAO from 2011-2021.
AMN Healthcare CFO Jeffrey Knudson to step down November 8; reaffirms Q3 2024 guidance
CFO Jeffrey Knudson will step down on November 8, 2024 to pursue an opportunity outside healthcare staffing.
AMN Healthcare Q2 2024 revenue $741M (-25% YoY); GAAP EPS $0.42, adjusted EPS $0.98
Revenue $740.7M, down 25% vs Q2 2023 $1,561.6M; gross profit $229.8M (-30% YoY).
AMN Healthcare Q1 revenue $821M (-27% YoY); GAAP EPS $0.45 (-78%), adjusted EPS $0.97 (-61%)
Revenue $820.9M, down 27% from $1.12B in Q1 2023.
On February 4, 2025, Douglas D. Wheat, the Chairman of the Board of Directors (the “Board”) of AMN Healthcare Services, Inc. (the “Company”) notified the Company of his decision to retire from the Board, effective immediately.
Mark G. Foletta was appointed to serve as Chairman of the Board.
the Board has appointed Mark G. Foletta, a member of the Board since 2012, to serve as Chairman of the Board, effective as of the completion of the 2025 Annual Meeting, subject to his re-election to the Board at the 2025 Annual Meeting.
Douglas D. Wheat, the Chairman of the Board of Directors (the “Board”) of AMN Healthcare Services, Inc. (the “Company”) notified the Company and the Board that he will not stand for re-election at the Company’s 2025 annual meeting of shareholders (the “2025 Annual Meeting”), at which time he will retire from the Board.
On October 3, 2024, AMN Healthcare Services, Inc. (“AMN” or the “Company”) announced that Brian Scott will join AMN as its Chief Financial Officer and Chief Operating Officer (“CFO/COO”) reporting to Cary Grace, AMN’s President and Chief Executive Officer.
the departure of Jeffrey Knudson from his role as the Company’s CFO, effective November 8, 2024, to pursue an opportunity with a private company outside of the healthcare industry.
On October 1, 2024, the Company announced that Jeffrey Knudson will step down from his role as Chief Financial Officer of the Company, effective November 8, 2024, to pursue an opportunity with a private company outside of the healthcare staffing industry.
voted to increase the size of the Board from eight to nine members, and to elect Mr. James H. Hinton as a new director to fill the vacancy created by such increase, with such appointment effective July 22, 2024.
Max materiality 0.80 · Median 0.60 · Most common event earnings